TScan Therapeutics Stock Forecast

TCRX's stock price has decreased by -75.73% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 6 professional analysts, the 12-month price target for TScan Therapeutics stock ranges from a low of $3.00 to a high of $15. The average analyst price target of $8.50 forecasts a 687.04% increase in the stock price over the next year.

Price Target: $8.50 (+687.04%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$8.50	$10	$15
Change	+177.78%	+687.04%	+825.93%	+1288.9%

Analyst Ratings

The average analyst rating for TScan Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	4	4	4	4	4	4
Buy	3	3	3	3	3	2
Hold	0	0	0	0	0	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andres Y. Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $10 → $7	Strong Buy	Maintains	$10 → $7	+548.15%	Nov 13, 2025
Justin Zelin BTIG	BTIG	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 4, 2025
Gil Blum Needham	Needham	Strong Buy Maintains $9 → $6	Strong Buy	Maintains	$9 → $6	+455.56%	Nov 4, 2025
Andres Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $15 → $10	Strong Buy	Maintains	$15 → $10	+825.93%	May 7, 2025
Gil Blum Needham	Needham	Strong Buy Reiterates $9	Strong Buy	Reiterates	$9	+733.33%	Apr 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

10.89M

from 2.82M

286.83%

from 2.82M

Revenue Next Year

10.44M

from 10.89M

-4.12%

from 10.89M

EPS This Year

-1.10

from -2.25

EPS Next Year

-0.96

from -1.10

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.09M	10.14M	13.54M	21.05M	2.82M	10.89M	10.44M
Revenue Growth	-	834.65%	33.47%	55.52%	-86.62%	286.83%	-4.12%
EPS	-28.52	-4.17	-2.75	-1.87	-2.25	-1.10	-0.96
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	15.8M	25.4M
Avg	10.9M	10.4M
Low	8.1M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	459.3%	133.1%
Avg	286.8%	-4.1%
Low	188.8%	-

EPS Forecast

EPS	2025	2026
High	-1.06	-0.69
Avg	-1.10	-0.96
Low	-1.11	-1.45

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.